Clinical Trials Browser

Nasopharyngeal Carcinoma × Cetuximab × Clear all

NCT05063552 2026-03-18

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT04508816 2022-04-04

Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

Phase 2 Completed

45 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02633176 2015-12-17

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

Phase 3 Unknown

120 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01712919 2014-03-24

Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)

Phase 1/2 Completed

61 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01271439 2013-08-13

REPLACE

Phase 2 Completed

60 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01614938 2012-06-08

Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer

Phase 2 Unknown

46 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00700440 2010-03-26

ENCORE

Phase 2 Completed

100 enrolled 4 charts

Head & Neck

Nasopharyngeal Carcinoma